Intraperitoneal docetaxel

DRUG3 trials

Sponsors

The University of Hong Kong, Fudan University, Johns Hopkins University

Conditions

Gastric CancerPeritoneal CarcinomatosisPeritoneal MetastasisStomach Neoplasms

Phase 1

Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis

CompletedNCT02024841

The University of Hong KongGastric Cancer, Peritoneal Carcinomatosis

Start: 2013-12-31End: 2018-03-31Updated: 2018-05-04

Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

TerminatedNCT04583488

Johns Hopkins UniversityPeritoneal Carcinomatosis

Start: 2020-11-01End: 2024-08-06Updated: 2024-08-09

Phase 2

The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites

Fudan UniversityPeritoneal Metastasis, Stomach Neoplasms

Start: 2017-01-20End: 2018-06-30Target: 50Updated: 2017-01-24

Related Papers

Feasibility study of intraperitoneal docetaxel combined with intravenous cisplatin and oral S-1 for gastric cancer patients with peritoneal carcinomatosis

Annals of Oncology2018-06-012 citations